Depression, anxiety and apathy are distinct neuropsychiatric symptoms that highly overlap in Parkinson's disease (PD). It remains unknown whether each symptom is uniquely associated with a functional network dysfunction. Here, we examined whether individual differences in each neuropsychiatric symptom predict functional connectivity patterns in PD patients while controlling for all other symptoms and motor function. Resting-state functional connectivity MRI were acquired from 27 PD patients and 29 healthy controls. Widespread reduced functional connectivity was identified in PD patients and explained by either the neuropsychiatric or motor symptoms. Depression in PD predicted increased functional connectivity between the orbitofrontal, hippocampal complex, cingulate, caudate and thalamus. Apathy in PD predicted decreased caudate-thalamus and orbitofrontal-parahippocampal connectivity. Anxiety in PD predicted three distinct types of functional connectivity not described before: (i) increased limbic-orbitofrontal cortex; (ii) decreased limbic-dorsolateral prefrontal cortex and orbitofrontal-dorsolateral prefrontal cortices and (iii) decreased sensorimotor-orbitofrontal cortices. The first two types of functional connectivity suggest less voluntary and more automatic emotion regulation. The last type is argued to be specific to PD and reflect an impaired ability of the orbitofrontal cortex to guide goal-directed motor actions in anxious PD patients.

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine and General University Hospital Charles University Prague Czech Republic

Department of Radiology Na Homolce Hospital Prague Czech Republic

Edmond and Lily Safra Center for Brain Sciences The Hebrew University of Jerusalem Jerusalem Israel

MRI Lab The Human Biology Research Center Department of Medical Biophysics Hadassah Hebrew University Medical Center Jerusalem Israel

Zobrazit více v PubMed

Castrioto A, Thobois S, Carnicella S, Maillet A, Krack P. Emotional manifestations of PD: Neurobiological basis. Mov. Disord. 2016;31:1103–1113. doi: 10.1002/mds.26587. PubMed DOI

Barone P, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov. Disord. 2009;24:1641–1649. doi: 10.1002/mds.22643. PubMed DOI

Langston JW. The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann. Neurol. 2006;59:591–596. doi: 10.1002/ana.20834. PubMed DOI

Chaudhuri KR, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov. Disord. 2006;21:916–923. doi: 10.1002/mds.20844. PubMed DOI

Nègre-Pagès L, et al. Anxious and depressive symptoms in Parkinson’s disease: the French cross-sectionnal DoPaMiP study. Mov. Disord. 2010;25:157–166. doi: 10.1002/mds.22760. PubMed DOI

Aarsland D, et al. Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J. Neurol. Neurosurg. Psychiatry. 2007;78:36–42. doi: 10.1136/jnnp.2005.083113. PubMed DOI PMC

Dissanayaka NNW, et al. Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov. Disord. 2010;25:838–845. doi: 10.1002/mds.22833. PubMed DOI

Starkstein SE, et al. The syndromal validity and nosological position of apathy in Parkinson’s disease. Mov. Disord. 2009;24:1211–1216. doi: 10.1002/mds.22577. PubMed DOI

Wen M-C, Chan LL, Tan LCS, Tan EK. Depression, anxiety, and apathy in Parkinson’s disease: insights from neuroimaging studies. Eur. J. Neurol. 2016;23:1001–1019. doi: 10.1111/ene.13002. PubMed DOI PMC

Luo C, et al. Resting-state fMRI study on drug-naive patients with Parkinson’s disease and with depression. J. Neurol. Neurosurg. Psychiatry. 2014;85:675–683. doi: 10.1136/jnnp-2013-306237. PubMed DOI

Sheng K, et al. Altered Spontaneous Brain Activity in Patients with Parkinson’s Disease Accompanied by Depressive Symptoms, as Revealed by Regional Homogeneity and Functional Connectivity in the Prefrontal-Limbic System. PLoS One. 2014;9:e84705. doi: 10.1371/journal.pone.0084705. PubMed DOI PMC

Wei L, et al. Aberrant Intra- and Internetwork Functional Connectivity in Depressed Parkinson’s Disease. Sci. Rep. 2017;7:2568. doi: 10.1038/s41598-017-02127-y. PubMed DOI PMC

Lou Y, et al. Altered brain network centrality in depressed Parkinson’s disease patients. Mov. Disord. 2015;30:1777–1784. doi: 10.1002/mds.26321. PubMed DOI

Skidmore FM, et al. Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage. 2013;81:484–495. doi: 10.1016/j.neuroimage.2011.07.012. PubMed DOI

Hecht D. Depression and the hyperactive right-hemisphere. Neurosci. Res. 2010;68:77–87. doi: 10.1016/j.neures.2010.06.013. PubMed DOI

Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 2003;65:193–207. doi: 10.1093/bmb/65.1.193. PubMed DOI

Liang P, et al. Altered directional connectivity between emotion network and motor network in Parkinson’s disease with depression. Medicine. 2016;95:e4222. doi: 10.1097/MD.0000000000004222. PubMed DOI PMC

Erro R, et al. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson’s disease patients. Parkinsonism Relat. Disord. 2012;18:1034–1038. doi: 10.1016/j.parkreldis.2012.05.022. PubMed DOI

Moriyama TS, et al. Increased dopamine transporter density in Parkinson’s disease patients with Social Anxiety Disorder. J. Neurol. Sci. 2011;310:53–57. doi: 10.1016/j.jns.2011.06.056. PubMed DOI

Weintraub D, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson’s disease. J. Nucl. Med. 2005;46:227–232. PubMed

Schapira AH, Ray Chaudhuri K, Jenner P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 2017;18:435–450. doi: 10.1038/nrn.2017.62. PubMed DOI

Shin LM, Liberzon I. The Neurocircuitry of Fear, Stress, and Anxiety Disorders. Neuropsychopharmacology. 2010;35:169–191. doi: 10.1038/npp.2009.83. PubMed DOI PMC

Taylor JM, Whalen PJ. Neuroimaging and Anxiety: the Neural Substrates of Pathological and Non-pathological Anxiety. Curr. Psychiatry Rep. 2015;17:49. doi: 10.1007/s11920-015-0586-9. PubMed DOI

Sylvester CM, et al. Functional network dysfunction in anxiety and anxiety disorders. Trends Neurosci. 2012;35:527–535. doi: 10.1016/j.tins.2012.04.012. PubMed DOI PMC

Kim MJ, Gee DG, Loucks RA, Davis FC, Whalen PJ. Anxiety Dissociates Dorsal and Ventral Medial Prefrontal Cortex Functional Connectivity with the Amygdala at Rest. Cereb. Cortex. 2011;21:1667–1673. doi: 10.1093/cercor/bhq237. PubMed DOI PMC

Hahn A, et al. Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder. Neuroimage. 2011;56:881–889. doi: 10.1016/j.neuroimage.2011.02.064. PubMed DOI

Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD. Disrupted Amygdalar Subregion Functional Connectivity and Evidence of a Compensatory Network in Generalized Anxiety Disorder. Arch. Gen. Psychiatry. 2009;66:1361. doi: 10.1001/archgenpsychiatry.2009.104. PubMed DOI

Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol. Psychiatry. 2008;13:833–857. doi: 10.1038/mp.2008.65. PubMed DOI PMC

Balleine BW, O’Doherty JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2010;35:48–69. doi: 10.1038/npp.2009.131. PubMed DOI PMC

Redgrave P, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat. Rev. Neurosci. 2010;11:760–772. doi: 10.1038/nrn2915. PubMed DOI PMC

de Wit S, Barker RA, Dickinson AD, Cools R. Habitual versus goal-directed action control in Parkinson disease. J. Cogn. Neurosci. 2011;23:1218–1229. doi: 10.1162/jocn.2010.21514. PubMed DOI

FitzGerald TH, Friston KJ, Dolan RJ. Action-specific value signals in reward-related regions of the human brain. J. Neurosci. 2012;32:16417–16423a. doi: 10.1523/JNEUROSCI.3254-12.2012. PubMed DOI PMC

Schoenbaum G, Roesch M. Orbitofrontal cortex, associative learning, and expectancies. Neuron. 2005;47:633–636. doi: 10.1016/j.neuron.2005.07.018. PubMed DOI PMC

Dias-Ferreira E, et al. Chronic stress causes frontostriatal reorganization and affects decision-making. Science. 2009;325:621–625. doi: 10.1126/science.1171203. PubMed DOI

Schwabe L, Wolf OT. Stress-induced modulation of instrumental behavior: from goal-directed to habitual control of action. Behav. Brain Res. 2011;219:321–328. doi: 10.1016/j.bbr.2010.12.038. PubMed DOI

Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb. Cortex. 2006;16:916–928. doi: 10.1093/cercor/bhj043. PubMed DOI

Wang X, et al. Cerebral metabolic change in Parkinson’s disease patients with anxiety: A FDG-PET study. Neurosci. Lett. 2017;653:202–207. doi: 10.1016/j.neulet.2017.05.062. PubMed DOI

Baggio HC, et al. Resting-state frontostriatal functional connectivity in Parkinson’s disease-related apathy. Mov. Disord. 2015;30:671–679. doi: 10.1002/mds.26137. PubMed DOI

Le Jeune F, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology. 2009;73:1746–1751. doi: 10.1212/WNL.0b013e3181c34b34. PubMed DOI

Santangelo G, et al. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson’s disease patients. Parkinsonism Relat. Disord. 2015;21:489–493. doi: 10.1016/j.parkreldis.2015.02.015. PubMed DOI

Robert GH, et al. Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study. Neurology. 2014;83:1620–1626. doi: 10.1212/WNL.0000000000000941. PubMed DOI

Luo C, et al. Reduced functional connectivity in early-stage drug-naive Parkinson’s disease: a resting-state fMRI study. Neurobiol. Aging. 2014;35:431–441. doi: 10.1016/j.neurobiolaging.2013.08.018. PubMed DOI

Tessitore A, et al. Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology. 2012;79:2226–2232. doi: 10.1212/WNL.0b013e31827689d6. PubMed DOI

Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson’s disease. Brain. 2012;135:3699–3711. doi: 10.1093/brain/aws281. PubMed DOI PMC

New AB, et al. The intrinsic resting state voice network in Parkinson’s disease. Hum. Brain Mapp. 2015;36:1951–1962. doi: 10.1002/hbm.22748. PubMed DOI PMC

Witjas T, et al. Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology. 2002;59:408–413. doi: 10.1212/WNL.59.3.408. PubMed DOI

Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 1992;55:181–184. doi: 10.1136/jnnp.55.3.181. PubMed DOI PMC

Deuschl G, et al. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson’s disease: Concept and standards of the EARLYSTIM-study. Park. Relat. Disord. 2013;19:56–61. doi: 10.1016/j.parkreldis.2012.07.004. PubMed DOI

Fahn, S. & Elton, R. In Recent developments in Parkinson’s Disease (eds Fahn, S., Marsden, C., Calne, D. & Goldstein, M.) 153–63 (FlorhamPark, NJ: MacMillanHealthCare, 1987).

Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio. 1996;78:490–8.

Spielberger, C. D., Gorsuch, R. L. & Lushene, R. E. Manual for the State-Trait Anxiety Inventory. Palo Alto (1970).

Starkstein SE, et al. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci. 1992;4:134–139. doi: 10.1176/jnp.4.2.134. PubMed DOI

Leentjens AF, et al. Apathy and anhedonia rating scales in Parkinson’s disease: Critique and recommendations. Mov. Disord. 2008;23:2004–2014. doi: 10.1002/mds.22229. PubMed DOI

Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x. PubMed DOI

Litvan I, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov. Disord. 2012;27:349–356. doi: 10.1002/mds.24893. PubMed DOI PMC

Bezdicek, O. et al. The Diagnostic Accuracy of Parkinson’s Disease Mild Cognitive Impairment Battery Using the Movement Disorder Society Task Force Criteria. Mov. Disord. Clin. Pract. (2016). PubMed PMC

Solomon SR, Sawilowsky SS. Impact of Rank-Based Normalizing Transformations on the Accuracy of Test Scores. J. Mod. Appl. Stat. Methods. 2009;8:448–462. doi: 10.22237/jmasm/1257034080. DOI

Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–141. doi: 10.1089/brain.2012.0073. PubMed DOI

Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage. 2007;37:90–101. doi: 10.1016/j.neuroimage.2007.04.042. PubMed DOI PMC

Muschelli J, et al. Reduction of motion-related artifacts in resting state fMRI using aCompCor. Neuroimage. 2014;96:22–35. doi: 10.1016/j.neuroimage.2014.03.028. PubMed DOI PMC

Chai XJ, Castañón AN, Öngür D, Whitfield-Gabrieli S. Anticorrelations in resting state networks without global signal regression. Neuroimage. 2012;59:1420–1428. doi: 10.1016/j.neuroimage.2011.08.048. PubMed DOI PMC

Tzourio-Mazoyer N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–289. doi: 10.1006/nimg.2001.0978. PubMed DOI

Xia M, Wang J, He Y. BrainNet Viewer: a network visualization tool for human brain connectomics. PLoS One. 2013;8:e68910. doi: 10.1371/journal.pone.0068910. PubMed DOI PMC

Yekutieli D, Benjamini Y. Resampling-based false discovery rate controlling multiple test procedures for correlated test statistics. J. Stat. Plan. Inference. 1999;82:171–196. doi: 10.1016/S0378-3758(99)00041-5. DOI

Tomlinson CL, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov. Disord. 2010;25:2649–2653. doi: 10.1002/mds.23429. PubMed DOI